Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xiaolong, Li, Cheng, Huang, Ailing, Xia, Shuai, Lu, Sicong, Shi, Zhengli, Lu, Lu, Jiang, Shibo, Yang, Zhenlin, Wu, Yanling, Ying, Tianlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048180/
https://www.ncbi.nlm.nih.gov/pubmed/32065055
http://dx.doi.org/10.1080/22221751.2020.1729069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048180/
https://www.ncbi.nlm.nih.gov/pubmed/32065055
http://dx.doi.org/10.1080/22221751.2020.1729069

Ejemplares similares